Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: Data from 242 cases included in the CryoVas survey

Annals of the Rheumatic Diseases

Volumn 72, Issue 3, 2013, Pages 374-380

  Terrier, Benjamin ^a   Carrat, Fabrice ^b   Krastinova, Evguenia ^b   Marie, Isabelle ^c   Launay, David ^d   Lacraz, Adeline ^e   Belenotti, Pauline ^f   De Saint Martin, Luc ^g   Quemeneur, Thomas ^h   Huart, Antoine ⁱ   Bonnet, Fabrice ^e   Guenno, Guillaume Le ^j   Kahn, Jean Emmanuel ^k   Hinschberger, Olivier ^l   Rullier, Patricia ^m   Hummel, Aurelie ⁿ   Diot, Elisabeth ^o   Pagnoux, Christian ⁿ   Lzaro, Estibaliz ^e   Bridoux, Frank ^p   Zenone, Thierry ^q   Hermine, Olivier ⁿ   Leger, Jean Marc ⁿ   Mariette, Xavier ^r   Senet, Patricia ⁿ   Plaisier, Emmanuelle ⁿ   Cacoub, Patrice ^s   more..

^a université Paris Cité   (France)

^b Biostatistics Department   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^g BREST UNIVERSITY HOSPITAL   (France)

^h Department of Internal Medicine   (France)

ⁱ TOULOUSE UNIVERSITY HOSPITAL   (France)

^j UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^k CHU   (France)

^l CHU   (France)

^m MONTPELLIER UNIVERSITY HOSPITAL   (France)

ⁿ Section of Radiology   (France)

^o UNIVERSITY HOSPITAL OF TOURS   (France)

^p POITIERS UNIVERSITY HOSPITAL   (France)

^q Department of Internal Medicine   (France)

^r BICÊTRE HOSPITAL   (France)

^s PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; CAUSE OF DEATH; CRYOGLOBULINEMIA; DISEASE EXACERBATION; FEMALE; FIVE FACTOR SCORE 2009; FOLLOW UP; GASTROINTESTINAL DISEASE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; INFECTION; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INFECTIOUS MIXED CRYOGLOBULINEMIA VASCULITIS; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SURVIVAL; VASCULITIS;

AGED; AREA UNDER CURVE; CRYOGLOBULINEMIA; DATA COLLECTION; FEMALE; GENETIC DISEASES, INBORN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VASCULITIS;

EID: 84873744947     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201405     Document Type: Review

References (25)

1. Brouet JC, Clauvel J P, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775-88.
2. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 1999;42:2204-12.
3. Trejo O, Ramos-Casals M, García-Carrasco M, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001;80:252-62.
4. Saadoun D, Sellam J, Ghillani-Dalbin P, et al. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 2006;166:2101-8.
5. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Pathol 2002;55:4-13.
6. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
7. Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004;33:355-74.
8. Tarantino A, Campise M, Banfi G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 1995;47:618-23.
9. Meltzer M, Franklin EC, Elias K, et al. Cryoglobulinemia - a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966;40:837-56.
10. Della Rossa A, Tavoni A, D'Ascanio A, et al. Mortality rate and outcome factors in mixed cryoglobulinaemia: the impact of hepatitis C virus. Scand J Rheumatol 2010;39:167-70.
11. Ramos-Casals M, Robles A, Brito-Zerón P, et al. Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases. Semin Arthritis Rheum 2006;36:189-96.
12. Terrier B, Semoun O, Saadoun D, et al. Prognostic factors in patients with hepatitis C virus infection and systemic vasculitis. Arthritis Rheum 2011;63:1748-57.
13. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997;337:1512-23.
14. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009:523-31.
15. Moons KG, Harrell FE, Steyerberg EW. Should scoring rules be based on odds ratios or regression coefficients? J Clin Epidemiol 2002;55:1054-5.
16. Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92-106.
17. Royston P, Moons KG, Altman DG, et al. Prognosis and prognostic research: Developing a prognostic model. BMJ 2009;338:b604.
18. Steyerberg EW, Harrell FE Jr, Borsboom GJ, et al. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-81.
19. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
20. Guillevin L, Pagnoux C, Seror R, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011;90:19-27.
21. Cacoub P, Lidove O, Maisonobe T, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002;46:3317-26.
22. Saadoun D, Resche-Rigon M, Thibault V, et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term followup study. Arthritis Rheum 2006;54:3696-706.
23. Terrier B, Launay D, Kaplanski G, et al. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry. Arthritis Care Res (Hoboken) 2010;62:1787-95.
24. Guillevin L, Lhote F, Gayraud M, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996;75:17-28.
25. Gayraud M, Guillevin L, le Toumelin P, et al. Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001;44:666-75.